Opening the door to backroom biologics

Automated benchtop systems are beginning to integrate oligonucleotide synthesis and protein production. Given economic pressures to innovate in drug manufacture and the potential of platform production technologies to enable decentralization, a future in which the brand manufacturers’ monopoly on biologics could be broken is feasible. 

Gene edits to ‘CRISPR babies’ might have shortened their life expectancy

Twin girls whose genomes were editied to make them resistant to HIV might have a shortened life expectancy as people with two disabled copies of the CCR5 gene — which protects against HIV infection — are 21 percent more likely to die before the age of 76 when compared to people with at least one working copy of the gene.